Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

OriginalsprogEngelsk
TidsskriftThe Journal of clinical endocrinology and metabolism
Vol/bind101
Udgave nummer2
Sider (fra-til)L22-L23
ISSN0021-972X
DOI
StatusUdgivet - feb. 2016

ID: 177292788